NCT00035035已完成3 期
A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 114
研究概览
简要总结
Definition: This study will compare the drug GEMZAR to a combination of GEMZAR plus ALIMTA for the treatment of cancer of the pancreas. Patients may be able to participate in this study if they have cancer in their pancreas that cannot be removed by surgery OR that has spread to a new site in their body.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pancreas cancer that cannot be removed by surgery OR that has spread to a new site in your body.
- •You must have one tumor that can be physically measured or scanned by the doctor.
- •You have not had any chemotherapy, immunotherapy, biologic therapy, or hormonal therapy for pancreas cancer, including 5-FU.
- •You cannot have any radiation for 4 weeks before starting this study, and you cannot have radiation to the whole pelvis.
排除标准
- •Treatment with any medication or device that has not been approved by regulatory agencies, like the FDA, at the time you enter the study.
- •Documentation that the cancer has spread to your brain.
- •Pregnant or breastfeeding.
- •A second primary cancer.
- •Unable to stop aspirin or non-steroidal anti-inflammatory agents (like ibuprofen) for 5-8 days.
研究者
研究点 (114)
Loading locations...
相似试验
终止
2 期
Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung CancerNon-Small-Cell Lung CancerNCT00383331Eli Lilly and Company19
终止
2 期
Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal CancerPeritoneal CancerOvarian CancerNCT00055432Eli Lilly and Company
已完成
不适用
A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.PER-030-02ELI LILLY INTERAMERICA INC.,
已完成
2 期
Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane TherapyBreast NeoplasmsBreast CancerNCT00063570Eli Lilly and Company73
已完成
3 期
A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerNon Small Cell Lung CarcinomaNCT00087711Eli Lilly and Company1,713